Spots Global Cancer Trial Database for Post-Ibrutinib Colitis and Intestinal Microbiota
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Post-Ibrutinib Colitis and Intestinal Microbiota
Official Title: Identification of Intestinal Microbiota Biomarkers Predictive of Diarrhea in Patients Treated by Ibrutinib.
Study ID: NCT03569137
Conditions
Gastrointestinal Microbiome
Interventions
Study Description
Brief Summary: Identify gut microbiome biomarkers associated with colitis in patients treated with targeted therapy in hematology
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU de Nantes, Nantes, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
